216 related articles for article (PubMed ID: 24318876)
21. CCAAT/enhancer-binding protein alpha (C/EBPalpha) and hepatocyte nuclear factor 4alpha (HNF4alpha) synergistically cooperate with constitutive androstane receptor to transactivate the human cytochrome P450 2B6 (CYP2B6) gene: application to the development of a metabolically competent human hepatic cell model.
Benet M; Lahoz A; Guzmán C; Castell JV; Jover R
J Biol Chem; 2010 Sep; 285(37):28457-71. PubMed ID: 20622021
[TBL] [Abstract][Full Text] [Related]
22. Two novel cis-elements involved in hepatocyte nuclear factor 4α regulation of acyl-coenzyme A:cholesterol acyltransferase 2 expression.
Zhang Z; Liu J; Xi Y; Yang R; Chen H; Li Z; Liu D; Liang C
Acta Biochim Biophys Sin (Shanghai); 2012 Feb; 44(2):162-71. PubMed ID: 22155889
[TBL] [Abstract][Full Text] [Related]
23. All-trans-retinoic acid ameliorates hepatic steatosis in mice by a novel transcriptional cascade.
Kim SC; Kim CK; Axe D; Cook A; Lee M; Li T; Smallwood N; Chiang JY; Hardwick JP; Moore DD; Lee YK
Hepatology; 2014 May; 59(5):1750-60. PubMed ID: 24038081
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional regulation of the human hepatic lipase (LIPC) gene promoter.
Rufibach LE; Duncan SA; Battle M; Deeb SS
J Lipid Res; 2006 Jul; 47(7):1463-77. PubMed ID: 16603721
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-1 controls the constitutive expression of the Cyp7a1 gene by regulating the expression of Cyp7a1 transcriptional regulators in the mouse liver.
Kojima M; Ashino T; Yoshida T; Iwakura Y; Degawa M
Biol Pharm Bull; 2011; 34(10):1644-7. PubMed ID: 21963511
[TBL] [Abstract][Full Text] [Related]
26. Orphan nuclear receptor small heterodimer partner negatively regulates growth hormone-mediated induction of hepatic gluconeogenesis through inhibition of signal transducer and activator of transcription 5 (STAT5) transactivation.
Kim YD; Li T; Ahn SW; Kim DK; Lee JM; Hwang SL; Kim YH; Lee CH; Lee IK; Chiang JY; Choi HS
J Biol Chem; 2012 Oct; 287(44):37098-108. PubMed ID: 22977252
[TBL] [Abstract][Full Text] [Related]
27. Induction of CYP2D6 in pregnancy.
Wadelius M; Darj E; Frenne G; Rane A
Clin Pharmacol Ther; 1997 Oct; 62(4):400-7. PubMed ID: 9357391
[TBL] [Abstract][Full Text] [Related]
28. Marsdenia tenacissima extract inhibits gefitinib metabolism in vitro by interfering with human hepatic CYP3A4 and CYP2D6 enzymes.
Han SY; Zhao HY; Zhou N; Zhou F; Li PP
J Ethnopharmacol; 2014; 151(1):210-7. PubMed ID: 24157377
[TBL] [Abstract][Full Text] [Related]
29. Peroxisome proliferator-activated receptor-gamma coactivator-1alpha activation of CYP7A1 during food restriction and diabetes is still inhibited by small heterodimer partner.
Shin DJ; Osborne TF
J Biol Chem; 2008 May; 283(22):15089-96. PubMed ID: 18385139
[TBL] [Abstract][Full Text] [Related]
30. Determinants of Cytochrome P450 2D6 mRNA Levels in Healthy Human Liver Tissue.
Ning M; Duarte JD; Stevison F; Isoherranen N; Rubin LH; Jeong H
Clin Transl Sci; 2019 Jul; 12(4):416-423. PubMed ID: 30821899
[TBL] [Abstract][Full Text] [Related]
31. Genetic polymorphism of hepatocyte nuclear factor-4alpha influences human cytochrome P450 2D6 activity.
Lee SS; Cha EY; Jung HJ; Shon JH; Kim EY; Yeo CW; Shin JG
Hepatology; 2008 Aug; 48(2):635-45. PubMed ID: 18666237
[TBL] [Abstract][Full Text] [Related]
32. Repression of hepatocyte nuclear factor 4 alpha by AP-1 underlies dyslipidemia associated with retinoic acid.
Won KJ; Park JS; Jeong H
J Lipid Res; 2019 Apr; 60(4):794-804. PubMed ID: 30709899
[No Abstract] [Full Text] [Related]
33. Human CYP2D6 and mouse CYP2Ds: organ distribution in a humanized mouse model.
Miksys SL; Cheung C; Gonzalez FJ; Tyndale RF
Drug Metab Dispos; 2005 Oct; 33(10):1495-502. PubMed ID: 16033950
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effect of the small heterodimer partner on hepatocyte nuclear factor-4 mediates bile acid-induced repression of the human angiotensinogen gene.
Shimamoto Y; Ishida J; Yamagata K; Saito T; Kato H; Matsuoka T; Hirota K; Daitoku H; Nangaku M; Yamagata K; Fujii H; Takeda J; Fukamizu A
J Biol Chem; 2004 Feb; 279(9):7770-6. PubMed ID: 14672953
[TBL] [Abstract][Full Text] [Related]
35. Small Heterodimer Partner Regulates Circadian Cytochromes p450 and Drug-Induced Hepatotoxicity.
Zhang T; Yu F; Guo L; Chen M; Yuan X; Wu B
Theranostics; 2018; 8(19):5246-5258. PubMed ID: 30555544
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the human cytochrome P4502D6 promoter. A potential role for antagonistic interactions between members of the nuclear receptor family.
Cairns W; Smith CA; McLaren AW; Wolf CR
J Biol Chem; 1996 Oct; 271(41):25269-76. PubMed ID: 8810289
[TBL] [Abstract][Full Text] [Related]
37. A RARE of hepatic Gck promoter interacts with RARα, HNF4α and COUP-TFII that affect retinoic acid- and insulin-induced Gck expression.
Li R; Zhang R; Li Y; Zhu B; Chen W; Zhang Y; Chen G
J Nutr Biochem; 2014 Sep; 25(9):964-76. PubMed ID: 24973045
[TBL] [Abstract][Full Text] [Related]
38. A Transcriptional Regulatory Network Containing Nuclear Receptors and Long Noncoding RNAs Controls Basal and Drug-Induced Expression of Cytochrome P450s in HepaRG Cells.
Chen L; Bao Y; Piekos SC; Zhu K; Zhang L; Zhong XB
Mol Pharmacol; 2018 Jul; 94(1):749-759. PubMed ID: 29691280
[TBL] [Abstract][Full Text] [Related]
39. Role of hepatocyte nuclear factors in transcriptional regulation of male-specific CYP2A2.
Wiwi CA; Waxman DJ
J Biol Chem; 2005 Feb; 280(5):3259-68. PubMed ID: 15539409
[TBL] [Abstract][Full Text] [Related]
40. Dexamethasone-mediated up-regulation of human CYP2A6 involves the glucocorticoid receptor and increased binding of hepatic nuclear factor 4 alpha to the proximal promoter.
Onica T; Nichols K; Larin M; Ng L; Maslen A; Dvorak Z; Pascussi JM; Vilarem MJ; Maurel P; Kirby GM
Mol Pharmacol; 2008 Feb; 73(2):451-60. PubMed ID: 17978169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
